Found: 1
Select item for more details and to access through your institution.
Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillation.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1344828
- By:
- Publication type:
- Article